Mapping of Epitopes of the Recombinant Movement Protein of the Tobacco Mosaic Virus with the Use of Monoclonal Antibodies

Autor: Stratonova Nv, Tiul'kina Lg, Karger Em, E. A. Sukhacheva, Dorokhov IuL, Sheveleva Aa

Publikováno v: Russian Journal of Bioorganic Chemistry. 31:433-438

The movement protein (MP) of the tobacco mosaic virus (TMV) provides the intercellular transport of the viral RNA through plasmodesmata. The MP fulfills its function while interacting with host cell factors over the whole path of its intracellular mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc005034feb2586c5b6230665118c303
https://doi.org/10.1007/s11171-005-0060-2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Electrophysiological and psychophysical studies in assessment of visual functions in patients with hereditary optic neuropathy].

Autor: Sheremet NL; Research Institute of Eye Diseases, Moscow, Russia., Ronzina IA; Research Institute of Eye Diseases, Moscow, Russia., Andreeva NA; Research Institute of Eye Diseases, Moscow, Russia., Zhorzholadze NV; Research Institute of Eye Diseases, Moscow, Russia., Murakhovskaya YK; Research Institute of Eye Diseases, Moscow, Russia., Nevinitsyna TA; Research Institute of Eye Diseases, Moscow, Russia., Shmelkova MS; Research Institute of Eye Diseases, Moscow, Russia., Krylova TD; Research Centre for Medical Genetics, Moscow, Russia., Tsygankova PG; Research Centre for Medical Genetics, Moscow, Russia., Gerasimidi ES; Institute of Mitoengineering of the Lomonosov Moscow State University, Moscow, Russia., Lyamzaev KG; Institute of Mitoengineering of the Lomonosov Moscow State University, Moscow, Russia.; A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia., Skulachev MV; Institute of Mitoengineering of the Lomonosov Moscow State University, Moscow, Russia.; A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia., Karger EM; Institute of Mitoengineering of the Lomonosov Moscow State University, Moscow, Russia.; A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia.

Publikováno v: Vestnik oftalmologii [Vestn Oftalmol] 2022; Vol. 138 (2), pp. 5-14.

Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.

Autor: Brzheskiy VV; Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation., Efimova EL; Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation., Vorontsova TN; Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation., Alekseev VN; North-Western State Medical University Named After I.I. Mechnikov, Saint Petersburg, Russian Federation., Gusarevich OG; Novosibirsk State Medical University, Novosibirsk, Russian Federation., Shaidurova KN; Novosibirsk State Medical University, Novosibirsk, Russian Federation., Ryabtseva AA; Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russian Federation., Andryukhina OM; Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russian Federation., Kamenskikh TG; Saratov State Medical University Named After V.I. Razumovsky, Saratov, Russian Federation., Sumarokova ES; Saratov State Medical University Named After V.I. Razumovsky, Saratov, Russian Federation., Miljudin ES; Samara State Medical University, Samara, Russian Federation., Egorov EA; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Lebedev OI; The Omsk State Medical Academy, Omsk, Russian Federation., Surov AV; The Omsk State Medical Academy, Omsk, Russian Federation., Korol AR; The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine, Odessa, Ukraine., Nasinnyk IO; The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine, Odessa, Ukraine., Bezditko PA; Kharkiv National Medical University, Kharkiv, Ukraine., Muzhychuk OP; Kharkiv National Medical University, Kharkiv, Ukraine., Vygodin VA; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation.; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation., Yani EV; Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation., Savchenko AY; Federal State Institution of Science Scientific Center of Biomedical Technology of the Federal Medical-Biological Agency of Russia, Svetlye Gory, Russian Federation., Karger EM; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation. karger@mitotech.ru.; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation. karger@mitotech.ru., Fedorkin ON; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation.; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation., Mironov AN; Limited Liability Company, National Medicines Agency, Moscow, Russian Federation., Ostapenko V; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation.; Federal State Budgetary Institution, Scientific Center for Expertise of Medical Application Products of the Ministry of Health, Moscow, Russian Federation., Popeko NA; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation., Skulachev VP; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation., Skulachev MV; Institute of Mitoengineering, Lomonosov Moscow State University, Moscow, Russian Federation.; Biological Faculty, Lomonosov Moscow State University, Moscow, Russian Federation.; Mitotech LLC, Moscow, Russian Federation.

Publikováno v: Advances in therapy [Adv Ther] 2015 Dec; Vol. 32 (12), pp. 1263-79. Date of Electronic Publication: 2015 Dec 11.